ロード中...
Rituximab therapy for hepatitis C virus‐associated cryoglobulinemic membranoproliferative glomerulonephritis
Membranoproliferative glomerulonephritis associated with mixed cryoglobulinemia is the most common form of kidney disease observed in relation to hepatitis C virus (HCV) infection. Rituximab, a monoclonal antibody against CD20, is an effective treatment for severe and/or refractory HCV‐related vascu...
保存先:
| 出版年: | Clin Case Rep |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5799646/ https://ncbi.nlm.nih.gov/pubmed/29445495 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.1371 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|